Unknown

Dataset Information

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics.


ABSTRACT: The influence of pharmacogenetics in tacrolimus pharmacokinetics and pharmacodynamics needs further investigation, considering its potential in assisting clinicians to predict the optimal starting dosage and the need for a personalized adjustment of the dose, as well as to identify patients at a high risk of rejection, drug-related adverse effects, or poor outcomes. In the past decade, new pharmacokinetic strategies have been developed to improve personalized tacrolimus treatment. Several studies have shown that patients with tacrolimus doses C0/D < 1 ng/mL/mg may demonstrate a greater incidence of drug-related adverse events and infections. In addition, C0 tacrolimus intrapatient variability (IPV) has been identified as a potential biomarker to predict poor outcom

SUBMITTER: Brunet M 

PROVIDER: S-EPMC9503558 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature